论文部分内容阅读
“重大新药创制”是我国政府于2008年提出并实施的一项大型科技计划专项。专项共设置“创新药物研究开发”、“药物大品种技术改造”、“创新药物研究开发技术平台建设”、“企业新药物孵化基地建设”和“新药研究开发关键技术研究”五个项目。“重大新药创制”政策意在研制具有自主知识产权的创新药物,建立和完善符合国际规范的新药研发平台,形成国家药物创新体系,提高自主创新能力,推动我国新药研究进程。该文分析了“重大新药创制”重大专项实施的政策保障及其效果,并对未来作出展望。
“Major new drug creation ” is a large-scale science and technology plan put forward and implemented by our government in 2008. Special set of “research and development of innovative drugs”, “large-scale transformation of drug technology”, “innovative drug research and development platform”, “enterprise new drug incubation base construction” and “new drug research and development Key Technology Research ”five projects. The policy of “major new drug creation” aims to develop innovative drugs with independent intellectual property rights, establish and perfect a new drug research and development platform in line with international norms, form a national drug innovation system, enhance the capability of independent innovation, and promote the research on new drugs in China. This article analyzes the policy guarantee and its effects of the implementation of the major special projects of “major new drug creation” and makes a prospect for the future.